Oramed Pharmaceuticals has developed an innovative technology to transform injectable treatments into oral therapies.
Established in 2006, has developed an oral insulin capsule, that has the potential to better the lives of millions of diabetics around the world – allowing, amongst other things, type 2 patients to begin insulin therapy earlier without fear of needles.
An experienced management team with many years of business and pharmaceutical background, backed by world-class scientific experts, is now developing an oral vaccine agaisnt covid-19.
In this live we will leran more about this innovation.